Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)

Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)

US Patent 9556487 · Granted Jan 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using miRNAs from bodily fluids for detection and differentiation of 2021
Methods of using miRNAs from bodily fluids for detection and differentiation of 2021
Methods of using miRNAs from bodily fluids for detection and differentiation of 2021
Methods of using miRNAs from bodily fluids for detection and monitoring of Parki2021
Methods of using miRNAs from bodily fluids for detection and monitoring of Parki2021
Methods of using miRNAs from bodily fluids for detection and monitoring of Parki2021
Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurod2021
Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurod2021
Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurod2021
miRNA-based methods for detecting and monitoring aging2020
miRNA-based methods for detecting and monitoring aging2020
miRNA-based methods for detecting and monitoring aging2020